TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3’ neo-enhancer
暂无分享,去创建一个
C. Plass | S. Spicuglia | U. Toprak | Oliver Mücke | D. Weichenhan | P. Lutsik | O. Hermine | V. Asnafi | Anna Riedel | A. Mayakonda | E. Allemand | A. Bakr | Charlotte Smith | A. Touzart | Etienne Sollier | Anastasija Pejkovska | M. Manojkumar | Estelle Balducci | Ashish Goyal | Kersten Breuer | Aliaa Bakr
[1] Kendall R. Sanson,et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities , 2018, Nature Communications.
[2] Jacob E Corn,et al. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA , 2016, Nature Biotechnology.
[3] B. Nadel,et al. Site- and allele-specific polycomb dysregulation in T-cell leukaemia , 2015, Nature Communications.
[4] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[5] A. Ferrando,et al. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. , 2004, Blood.
[6] E. Allemand,et al. Analysis of Splicing Regulation by Third-Generation Sequencing. , 2022, Methods in molecular biology.